nutch_noindex
CANCEL
/nutch_noindex

Jacquelyn Zirbes, MSN, Doctorate of Nursing Practice

  • Jacquelyn Zirbes

Specialties

Pulmonary Medicine/Cystic Fibrosis

Pediatrics

Work and Education

Professional Education

MSN, St Catherine University, St Paul, MN, 1991

Doctorate of Nursing Practice, University of Minnesota, Minneapolis, MN, 2007

Board Certifications

Board Certified Acute Care Pediatric Nurse Practitioner #20051279, 2005

Board Certified Primary Care Pediatric Nurse Practitioner #20051279/#90184, 1991

Registered Nurse with the State of Minnesota #R 109571-3 1986

Registered Nurse with the State of California #R 712243 2007

Registered Nurse Practitioner with the State of California NP#17736

Certified in Pediatric Advanced Life Support

Research Interests

Genotype phenotype relationships in children with cystic fibrosis diagnoses by newborn screening, lung ventilation measurements in infants with pulmonary disease, sweat chloride testing performance and CFTR mutations, clinical manifestations in patients with ciliary dyskensia

Honors and Award

Sigma Theta Tau, International Honorary Nursing Society, Chi Chapter

Fellow of the National Association of Pediatric Nurse Associates and Practitioners

Recipient, Doctorate of Nursing Research Grant, Sigma Theta Tau International, ZetaChapter

Recipient, Doctorate of Nursing Research Grant, Children with Special Health Care Needs

Publications

Zirbes, JM., Koepke, R., Kharrazi M, Milla CE. Sweat chloride testing performance and concentration by mutation class among infants identified by cystic fibrosis newborn screening in California. In preparation for submission to Journal of Pediatrics.

Koepke R., Keiles, S., Nickerson B, Pian M., Saeed M., Landon C., Nussbaum, E., Chin T., Shay G., Zirbes JM, Milla CE., Kharrazi M. Novel CFTR variants identified during the first two years of cystic fibrosis newborn screening in California. Submitted, Journal of Pediatrics.

Harrison, A., Regelmann, W., Zirbes, JM., and Milla, CE. Longitudinal assessment of lung function from infancy to childhood in patients with cystic fibrosis. Pediatric Pulmonolgy, 2009, 44: 464-471.

Zirbes, J. and Milla, C. Steroid-sparing effect of Omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatric Pulmonolgy, 2008, 43,6:067-610.

Hoffman F, Nelson B, Drangstveit MB, Flynn B, Watercott E, Zirbes JM.. Caring for transplant recipients in a nontransplant setting. Critical Care Nurse, 2006; 26: 53-73.

Zirbes, J. and Milla, C. Pulmonary Manifestations of Endocrine and Metabolic Disorders, Paediatric Respiratory Review, In press 2010.

Zirbes, J. and Milla, C. Cystic Fibrosis Related Diabetes. Paediatric Respiratory Review, 2009; 10(3): 118-123.